8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the Black/White Studio Steve Jobs Apple Headphone biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe studio high definition pink headphone retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, BMW Studio Grey Headphone the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in monster beats studio headphone pink the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. Monster beats studio black headphone The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and beats by dre studio limited edition grey headphone that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s studio high definition golden headphone Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since beats by dr dre studio limited edition green Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet studio Dallas Cowboys headphone black Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School black studio headphone from monster Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter White Studio Steve Jobs Apple Headphone earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker studio high definition purple headphone cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked high performance pro red headphone by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s pro high performance black/red headphone experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer studio black San Francisco 49ers headphone reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. Beats by dre studio headphone black The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee Grey studio limited edition headphone named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. studio pink diamond headphone The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the studio Kobe Bryant headphone average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the monster beats studio Pittsburgh Steelers headphone most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, Black/Yellow Solo HD headphone the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s studio high definition grey headphone (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 Beats by dre pro headphone black/yellow percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings studio blue diamond headphone of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings studio over-ear headphone blue/red that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, Blue diamond studio limited edition headphone the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human monster beats studio headphone grey genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad Philadelphia Phillies stuido headphone Claret/Deep Yellow forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals studio New York Yankees Headphone Grey from monster company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping dr dre beats studio Kobe Bryant headphone the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Black/White Studio Steve Jobs Apple Headphone Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief Black/Red Studio Milwaukee Brewers Headphone operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing monster beats studio ferrari headphone eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer pro headphone white/grey from monster electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former stuido headphone black/red Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone Studio Ferrari headphone by dre basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s black studio headphone (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, studio black headphone from monster Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange BMW Studio Grey Headphone E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) Solo HD On-ear Headphone White will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New beats by dr dre studio headphone pink York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on dr dre beats studio Kobe Bryant headphone this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private monster beats studio Steve Jobs Apple Headphone White equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce beats by dre studio claret/deep yellow headphone costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia purple solo on-ear headphone Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on beats by dre studio headphone black Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, studio high definition golden headphone Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With dr dre beats studio white headphone assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee studio black diamond headphone & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Cheap studio headphone blue Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since studio over-ear headphone April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and beats by dre stuido ferrari headphone earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an black studio headphone from monster analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for Solo HD On-ear Headphone Black this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index beats by dr dre studio headphone champagne changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower White/Grey Pro High Performance Headphone lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer Pink studio headphone is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer studio headphone yellow/red electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, beats by dre studio graffiti headphone the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast White diamond studio limited edition headphone after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne studio pink diamond headphone Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share Beats by dre Pro headphone white/red on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New Beats by dr dre pro headphone white/grey York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, beats by dre studio limited edition blue headphone and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Red Solo HD headphone Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop Black/Red Studio Milwaukee Brewers Headphone since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close beats by dr dre studio headphone champagne of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit Monster Beats Solo HD Black Headphone against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon blue/red over-ear studio headphone Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P dr dre beats studio Kobe Bryant headphone said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of grey stuido BMW headphone 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders beats by dr dre studio headphone grey for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain Monster beats studio white diamond headphone the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, pro high performance black/red headphone an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella pro over-ear red headphone resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The Black Solo HD headphone medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. beats by dre Pro Tough Times Neverlast headphone Black/Yellow The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of beats by dre New York Yankees studio headphone grey 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the beats by dre stuido ferrari headphone 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare dr dre beats studio grey headphone fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The Monster beats pro over-ear headphone black/red world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent limited edition LeBron James 23 headphone to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, Cheap pro black/red headphone to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, beats by dr dre studio headphone black a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, monster beats Graffiti Limited Edition studio headphone and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination Beats by dre pro headphone red of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The Grey studio headphone company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast Beats by dre pro Detox headphone black annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology beats by dre studio black headphone company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Beats by dre Pro headphone black/grey Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P orange headphone limited edition SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst beats by dre studio headphone black for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange Red diamond studio limited edition headphone E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will Studio over-ear headphone black be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic dr dre beats studio grey headphone copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related studio black San Francisco 49ers headphone macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research studio headphone green company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long pro headphone white/grey from monster experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange Beats by dre studio headphone black/orange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s monster beats studio headphone blue 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) Red Sox Studio headphone dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose Solo HD On-ear Headphone Black the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity cheap pro headphone white/grey on sale firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Red studio headphone Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. high definition purple solo hd headphone (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was limited edition LeBron James 23 headphone cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health solo white hd headphones from monster Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: studio high definition golden headphone Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS Philadelphia Phillies stuido headphone Claret/Deep Yellow US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store Tough Times Neverlast pro headphone from monster openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print dr dre beats studio headphone pink diamond READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in cheap pro headphone white/grey on sale a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent studio New York Yankees headphone grey to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer beats by dr dre studio headphone black/white is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
8-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive black studio high definition headphone and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at monster beats studio LeBron James23 headphone least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the beats by dre blue studio headphone most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap pro over-ear white/red headphone 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management dr dre studio headphone purple employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business black/grey dr dre beats studio headphone Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, monster beats studio Mike Jackson headphone the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of monster beats studio LeBron James23 headphone 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast monster beats studio ferrari headphone fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast beats by dr dre studio apple green headphone fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who studio high definition grey headphone has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed studio Kobe Bryant headphone holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for black/grey pro high performance headphone Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after studio Pittsburgh Steelers headphone blue meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. Studio limited edition blue diamond headphone from monster The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, dr dre beats studio grey headphone while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most beats by dre studio Graffiti Limited Edition over-ear Headphone since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, blue/red over-ear studio headphone the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, black studio high definition headphone will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. monster beats high performance pro headphone white/red 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 studio Red Sox over-ear headphone percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical orange studio headphone research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription studio high definition white headphone and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina studio high definition blue headphone Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the beats by dr dre studio apple green headphone S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. studio Chicago White Sox Violet headphone from monster Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to dr dre beats studio headphone blue 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably monster beats studio black/gray headphone be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. Black/White Studio Steve Jobs Apple Headphone The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter studio high definition grey headphone earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS studio limited edition headphone orange US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since beats by dre stuido headphone black/orange Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets White/Grey Pro Headphone from monster slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in monster beats studio ferrari headphone a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected studio headphone apple green 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. monster beats Graffiti Limited Edition studio headphone The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) Beats by dre studio San Francisco 49ers headphone black iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the Black Solo HD headphone most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings studio New York Yankees Headphone Grey from monster forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 1 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty studio headphone apple green Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter Studio black headphone by dre earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business beats by dre studio headphone black Exchange E-mail Print READER DISCUSSION
Comments (0)Post Comment View Whole Blog
7-Feb-2012 - Online Wholesale replica watches market » BorgWarner, Goodyear
Visted 6 timesBorgWarner, Goodyear, Lululemon, Tiffany U.S. Equ By Inyoung Hwang Jan. 10 (Bloomberg) — Shares of the following companies had unusual moves in U.S. market trading. Stock symbols are in parentheses, and prices are as of 4 p.m. in New York. Index changes: Carter’s Inc. (CRI US), the maker of children’s clothes, will replace 99 Cents Only Stores (NDN US) in the S&P MidCap 400 Index after the close on Jan. 13, while Virtus Investment Partners Inc. (VRTS US) will take Carter’s place in the S&P SmallCap 600 Index, S&P said. SunCoke Energy Inc. (SXC US) will replace School Specialty Inc. (SCHS US) in the S&P SmallCap 600 Index after the close of trading on Jan. 17, S&P said in a statement. Carter’s rose 2.9 percent to 41.54. Virtus advanced 7.3 percent to 82.88. School Specialty declined 4.4 percent to 2.40. Audiovox Corp. (VOXX US) gained the most since May 2009, advancing 21 percent to 10.89. The maker of automotive and consumer Monster beats pro over-ear headphone black/red electronics posted third-quarter sales and earnings that exceeded the single estimate in a Bloomberg survey, and forecast annual earnings higher than the average of two projections. BorgWarner Inc. (BWA US) climbed 12 percent, the biggest gain the Standard & Poor’s 500 Index, to 72.25. The maker of turbochargers forecast profit this year will be 5.35 to 5.65 a share. That tops the 5.17 average estimate of 19 analysts tracked by Bloomberg. Charles River Laboratories International Inc. (CRL US) advanced 17 percent, the second-most in the Russell 1000 Index, to 32.47. The medical research company will probably be broken up in a sale, with the research models and services group going to a private equity firm, and preclinical business getting a strategic buyer, according to Sterne Agee & Leach Inc. Cirrus Logic Inc. (CRUS US) surged 16 percent, the most since Jan. 27, to 19.64. The supplier of parts for Apple Inc.’s (AAPL US) iPhone and iPad forecast fourth-quarter revenue of 105 million, above the average analyst estimate of 98.5 million. Complete Genomics Inc. (GNOM US) dropped 24 percent Replica Watches, the most since Aug. 4, to 2.94. The Mountain View, California-based human genome sequencing company was cut to “market perform” from “outperform” Monster beats studio black headphone at Oppenheimer & Co. DSW Inc. (DSW US) jumped 13 percent, the most since May 24, to 48.11. The shoe retailer lifted its full-year earnings forecast and said it will accelerate store openings this year. Eastman Kodak Co. (EK US) gained the most in the Russell 2000 Index, advancing 50 percent to 60 cents. The unprofitable 131-year-old imaging company simplified its management structure and created a chief operating office to reduce costs. Emulex Corp. (ELX US) rose 13 percent, the most since April 2009, to 8.37. The chipmaker forecast second-quarter earnings of at least 24 cents a share. Analysts projected 17 cents a share, according to the average estimate in a Bloomberg survey. Francesca’s Holdings Corp. (FRAN US) rallied 12 percent, the most since Dec. 7, to 20.31. The Houston, Texas-based women’s apparel retailer raised its fourth-quarter earnings forecast to 16 cents a share to 17 cents a share from an earlier estimate of 14 cents to 15 cents. Analysts projected 15 cents a share on average. Goodyear Tire & Rubber Co. (GT US) dropped 8.3 percent, the most since Aug. 18, to 14.01. The largest U.S. tiremaker said it’s experiencing softness in global demand. Health Management Associates Inc. (HMA US) fell the second- most in the Russell 1000 Index, sliding 13 percent to 6.05. Sheryl Skolnick, an analyst for CRT Capital Group LLC, raised concerns about an October whistle-blower lawsuit against the operator of acute-care hospitals involving Medicare billing. The suit was filed by a former Health Management employee named Paul Meyer, who has “long experience” investigating Medicare fraud, Skolnick said. Hi-Tech Pharmacal Co. (HITK US) dropped 16 percent, the most since March 2, to 35.31. Wockhardt Ltd. (WPL IN) said it won Food and Drug Administration approval for generic copy of GlaxoSmithKline’s (GSK LN) Flonase nasal spray and plans to introduce the drug immediately. Hi-Tech, the Amityville, New York-based prescription and over-the-counter pharmaceuticals company, sells generic copies of the nasal spray. Lexicon Pharmaceuticals Inc. (LXRX US) rose 9.5 percent, the most since Dec. 30, to 1.27. The biotechnology company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than the DPP-4 inhibitor did on a stand-alone basis. Life Technologies Corp. (LIFE US) rose the second-most in the S&P 500, climbing 8.3 percent to 46.17. The provider of gene-analysis tools said it’s taking orders for the new benchtop Ion Proton Sequencer, designed to sequence the entire human genome in a day for 1,000. Illumina Inc. (ILMN US), which offers a competing product, HiSeq Replica Watches, rose 3.7 percent to 33.01. Liz Claiborne Inc. (LIZ US) tumbled 13 percent, the biggest drop since Aug. 8, to 8.64. The apparel maker cut its profit forecast for the coming year and said its chief financial officer is departing. Lululemon Athletica Inc. (LULU US) rose 12 percent, the most since December 2010, to 59.87. The yoga-wear retailer forecast fourth-quarter earnings of 47 cents a share to 49 cents a share, topping the average analyst estimate of 42 cents a share. Regeneron Pharmaceuticals Inc. (REGN US) increased 14 percent, the most since April 27, to 74.44. Fourth-quarter net sales for the company’s Eylea drug for wet age-related macular degeneration, a blindness-causing eye disorder, were more than four times what Cowen & Co. estimated. Signet Jewelers Ltd. (SIG US) declined 6.3 percent, the most since Aug. 18, to 44.05. The company forecast 2012 earnings of no more than 3.72 a share, below the average analyst estimate of 3.74 a share. Tiffany & Co. (TIF US) fell 10 percent, monster beats stuido headphone black/grey the most in the S&P 500, to 59.94. The world’s second-largest luxury jewelry retailer reduced its annual earnings forecast after volatile stock markets slowed holiday sales growth. WebMD Health Corp. (WBMD US) sank 29 percent, the most since July 18, to 26.25. The medical-information company said it terminated discussions with potential acquirers and that Wayne Gattinella resigned as chief executive officer. –With assistance from Whitney Kisling, Katia Porzecanski, Ksenia Galouchko, Nikolaj Gammeltoft and Lu Wang in New York. Editors: Stephen Kleege, Joanna Ossinger To contact the reporter on this story: Inyoung Hwang in New York at ihwang7@bloomberg.net To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net Business Exchange E-mail Print READER DISCUSSION
del.icio.us
Technorati